T
Travere Therapeutics D
D
TVTX
14.320
USD
-0.09
(-0.62%)
مغلق
حجم التداول
31,991
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
1,271,684,994
الأخبار المقالات
العنوان: Travere Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.